Menu
GeneBe

10-98420094-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000195.5(HPS1):c.1808A>G(p.Gln603Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.09 in 1,613,678 control chromosomes in the GnomAD database, including 7,029 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q603W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.11 ( 895 hom., cov: 33)
Exomes 𝑓: 0.088 ( 6134 hom. )

Consequence

HPS1
NM_000195.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.34
Variant links:
Genes affected
HPS1 (HGNC:5163): (HPS1 biogenesis of lysosomal organelles complex 3 subunit 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is a component of three different protein complexes termed biogenesis of lysosome-related organelles complex (BLOC)-3, BLOC4, and BLOC5. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 1. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on chromosome 22. [provided by RefSeq, Aug 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013628304).
BP6
Variant 10-98420094-T-C is Benign according to our data. Variant chr10-98420094-T-C is described in ClinVar as [Benign]. Clinvar id is 21099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-98420094-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HPS1NM_000195.5 linkuse as main transcriptc.1808A>G p.Gln603Arg missense_variant 18/20 ENST00000361490.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HPS1ENST00000361490.9 linkuse as main transcriptc.1808A>G p.Gln603Arg missense_variant 18/201 NM_000195.5 P1Q92902-1

Frequencies

GnomAD3 genomes
AF:
0.106
AC:
16067
AN:
152124
Hom.:
894
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.132
Gnomad AMI
AF:
0.0702
Gnomad AMR
AF:
0.110
Gnomad ASJ
AF:
0.125
Gnomad EAS
AF:
0.139
Gnomad SAS
AF:
0.0423
Gnomad FIN
AF:
0.134
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.0850
Gnomad OTH
AF:
0.115
GnomAD3 exomes
AF:
0.0999
AC:
25061
AN:
250894
Hom.:
1464
AF XY:
0.0948
AC XY:
12862
AN XY:
135674
show subpopulations
Gnomad AFR exome
AF:
0.136
Gnomad AMR exome
AF:
0.125
Gnomad ASJ exome
AF:
0.120
Gnomad EAS exome
AF:
0.145
Gnomad SAS exome
AF:
0.0390
Gnomad FIN exome
AF:
0.129
Gnomad NFE exome
AF:
0.0883
Gnomad OTH exome
AF:
0.109
GnomAD4 exome
AF:
0.0884
AC:
129145
AN:
1461436
Hom.:
6134
Cov.:
31
AF XY:
0.0869
AC XY:
63164
AN XY:
727018
show subpopulations
Gnomad4 AFR exome
AF:
0.140
Gnomad4 AMR exome
AF:
0.124
Gnomad4 ASJ exome
AF:
0.117
Gnomad4 EAS exome
AF:
0.121
Gnomad4 SAS exome
AF:
0.0410
Gnomad4 FIN exome
AF:
0.129
Gnomad4 NFE exome
AF:
0.0845
Gnomad4 OTH exome
AF:
0.0983
GnomAD4 genome
AF:
0.106
AC:
16081
AN:
152242
Hom.:
895
Cov.:
33
AF XY:
0.109
AC XY:
8100
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.132
Gnomad4 AMR
AF:
0.110
Gnomad4 ASJ
AF:
0.125
Gnomad4 EAS
AF:
0.140
Gnomad4 SAS
AF:
0.0424
Gnomad4 FIN
AF:
0.134
Gnomad4 NFE
AF:
0.0849
Gnomad4 OTH
AF:
0.114
Alfa
AF:
0.0916
Hom.:
1666
Bravo
AF:
0.107
TwinsUK
AF:
0.0782
AC:
290
ALSPAC
AF:
0.0882
AC:
340
ESP6500AA
AF:
0.139
AC:
614
ESP6500EA
AF:
0.0847
AC:
728
ExAC
AF:
0.0990
AC:
12023
Asia WGS
AF:
0.0930
AC:
324
AN:
3478
EpiCase
AF:
0.0876
EpiControl
AF:
0.0872

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Gln603Arg in exon 18 of HPS1: This variant is not expected to have clinical sign ificance because it has been identified in 13.9% (614/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs2296436). -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJul 25, 2019- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Hermansky-Pudlak syndrome 1 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Hermansky-Pudlak syndrome Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.71
Cadd
Benign
9.1
Dann
Benign
0.78
DEOGEN2
Benign
0.058
T;T;T
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.26
N
MetaRNN
Benign
0.0014
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-2.0
N;N;N
MutationTaster
Benign
0.020
P;P
PrimateAI
Benign
0.23
T
PROVEAN
Benign
1.0
N;N;.
REVEL
Benign
0.027
Sift
Benign
1.0
T;T;.
Sift4G
Benign
1.0
T;T;T
Vest4
0.016
MPC
0.15
ClinPred
0.0032
T
GERP RS
3.4
Varity_R
0.028
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2296436; hg19: chr10-100179851; COSMIC: COSV57268041; COSMIC: COSV57268041; API